tradingkey.logo

CMS plans sanctions suspending enrollment in Elevance's Medicare Advantage drug plans

ReutersMar 2, 2026 11:22 AM

- The Centers for Medicare & Medicaid Services has notified Elevance Health ELV.N it plans to impose sanctions that would stop the health insurer from enrolling members in its Medicare Advantage prescription drug plans, a filing showed on Monday.

The sanctions are scheduled to take effect on March 31, 2026, unless the agency determines the issues identified have been satisfactorily addressed.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI